SCHEMBL17984232

SCHEMBL17984232

Cc1cc(-c2ccc(F)c(F)c2)nc2c1CN(Cl)CC2

nearest known ligand 0.38

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
C5AR1 P21730 13/20 0.38
ALDH1A1 P00352 1/20 0.36
CYP1A2 P05177 1/20 0.36
GAA P10253 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
THRB P10828 1/20 0.35
TGFBR1 P36897 1/20 0.35
BRD4 O60885 1/20 0.32
CREBBP Q92793 1/20 0.32
GRM5 P41594 2/20 0.32
KCNH2 Q12809 1/20 0.31
CYP11B1 P15538 1/20 0.31
CYP11B2 P19099 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17984231 0.81 CLPP (0.52) C5AR1CYP1A2GAACYP2C9
SCHEMBL19674708 0.74 HTR2A (0.43) ALDH1A1CYP1A2GAACYP2C9CYP2C19
Hydrochloric Acid SCHEMBL19664791 0.73 HTR2A (0.43) ALDH1A1CYP1A2GAACYP2C9CYP2C19
SCHEMBL17984896 0.69 CYP2C9 (0.35) ALDH1A1CYP1A2CYP2C9CYP2C19THRB
SCHEMBL17985017 0.69 CYP2C19 (0.43) C5AR1ALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL19674740 0.68 CYP2C9 (0.44) ALDH1A1CYP1A2GAACYP2C9CYP2C19
SCHEMBL28162541 0.68 ALDH1A1 (0.35) ALDH1A1CYP1A2GAACYP2C9CYP2C19
SCHEMBL19674707 0.63 CYP2C9 (0.42) ALDH1A1CYP2C9CYP2C19GRM5
SCHEMBL23586188 0.62 PDE4B (0.54) ALDH1A1CYP1A2CYP2C19
SCHEMBL15948070 0.62 SOS1 (0.43) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3252059-A1 ANTI-PULMONARY TUBERCULOSIS NITROIMIDAZOLE DERIVATIVE Medshine Discovery Inc. (CN) 2017-12-06 EP disclosed
WO-2016119706-A1 ANTI-PULMONARY TUBERCULOSIS NITROIMIDAZOLE DERIVATIVE 南京明德新药研发股份有限公司 2016-08-04 WO disclosed